查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401166

恒温核酸增幅技术的全球市场：市场规模、占有率、趋势分析、机会和预测（2019-2029）

Isothermal Nucleic Acid Amplification Technology Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Technology ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球恒温核酸增幅技术（INAAT）市场规模预计在2023年至2029年间将增加一倍以上，2029年达到84.4亿美元。

由于人们越来越关注患病率上升的治疗和管理、快速和简化的检测，全球等恒温核酸增幅技术 (INAAT) 市场正在蓬勃发展。

领先的策略咨询和市场研究公司BlueWeave Consulting在最近的研究中估计，2022年全球恒温核酸增幅技术（INAAT）市场规模为42.1亿美元。 BlueWeave 预测，2023-2029 年预测期内，全球等恒温核酸增幅技术（INAAT）市场规模将以 12.29% 的复合年增长率显着成长，2029 年达到 84.4 亿美元。全球等恒温核酸增幅技术（INAAT）市场的主要成长动力包括感染疾病率的增加。结核病、肝炎和流感等疾病是感染疾病导致死亡的主要原因，特别是在开发中国家。因此，普及快速、易于使用、针对特定疾病的测试，INAAT 解决方案有望广泛应用。再加上单引子等温扩增（SPIA）、恒温环型核酸扩增（LAMP）、重组聚合酶扩增（RPA）和链置换扩增（SDA）等创新技术的引入，现有扩增技术的不断进步正在创造新的技术。INAAT 产品应用的可能性。预计这些发展将在预测期内提高 INAAT 的可接受性。此外，INAAT诊断及相关产品製造商之间的策略联盟预计将在扩大市场前景和促进行业成长方面发挥关键作用。然而，复杂的样品製备和市场竞争预计将在分析期间抑制整体市场的成长。

机会－INAAT在新兴市场的创新应用

恒温核酸增幅技术(INAAT) 产品的新应用源自于现有扩增技术的快速发展，例如单引子等温扩增(SPIA)、环介导等温扩增(LAMP)、重组酶聚合酶扩增( RPA) 和链位移：它是由扩增（SDA）等创新技术引起的。一个值得注意的例子是，2022 年 6 月发表在《分析师杂誌》上的一项研究利用 LAMP 技术展示了在智慧型手机整合设备中仅使用一滴血即可快速检测兹卡病毒。这些进步预计将在预测期内加深 INAAT 的渗透率。

COVID-19对全球等恒温核酸增幅技术市场的影响

COVID-19大流行对全球恒温核酸增幅技术（INAAT）市场产生了正面影响。这导致对用于识别 SARS-CoV-2（冠状病毒）的快速、准确的测试解决方案的需求显着增加。业内多家领先公司已宣布基于INAAT的新的COVID-19检测产品，并获得了美国FDA对这些产品的紧急使用核准。例如，该领域的商用产品包括 Grifols Diagnostic Solutions 的 Procleix SARS-CoV-2 检测试剂盒和 Lucira Health 的 Lucira CHECK-IT COVID-19检测套组。 COVID-19 大流行的挑战所引发的策略努力预计将在预测期内显着推动市场成长。

恒温核酸增幅技术 (INAAT) 的全球市场 – 按应用分类

按应用划分，全球恒温核酸增幅技术市场分为血液筛检、感染疾病诊断和癌症领域。感染疾病诊断领域在全球特定应用等恒温核酸增幅技术（INAAT）市场中占有最高占有率。由于肝炎、爱滋病毒、疱疹和流感等感染疾病呈上升趋势，核酸扩增套件可实现高效诊断和治疗，因此市场预计将扩大。越来越多地使用现场护理 (PoC) 诊断测试有助于感染疾病的早期管理、治疗和监测，从而有助于市场扩张。此外，人们对抗菌药物和传染病爆发的认识和关注的提高预计将对预测期内的市场成长产生积极影响。

恒温核酸增幅技术的全球市场－按地区

本研究报告考察了全球恒温核酸增幅技术 (INAAT) 市场，并涵盖五个主要地区的各个各国市场。这些地区是北美、欧洲、亚太地区、拉丁美洲和中东/非洲。北美在全球等恒温核酸增幅技术市场中占有最高占有率。该地区的优势在于慢性病的高盛行率、INAAT 的技术进步以及相对于传统技术向 INAAT 的转变。 2020 年，美国疾病管制与预防中心报告称，美国美国慢性病。根据GLOBOCAN 2020资料，美国新增癌症病例2281,658例，死亡病例612,390例。此外，北美的人均医疗保健支出预计将达到3,080亿美元，进一步推动市场成长。预计该地区的市场未来将继续扩大。

竞争形势

全球等恒温核酸增幅技术（INAAT）市场的主要企业包括Alere, Inc. Ltd.、Hologic Inc. (Gen-Probe)、Meridian Bioscience, Inc.、Ustar Biotechnologies Ltd.、QIAGEN、Quidel Corporation、Thermo Fisher Scientific , Inc.、BD (Becton, Dickinson & Company) 与OptiGene Limited。为了进一步增加市场占有率，这些公司正在采取各种策略，例如併购、合作、合资、授权协议和新产品发布。

该报告的详细分析提供了有关全球恒温核酸增幅技术（INAAT）市场的成长潜力、未来趋势和统计数据的资讯。它还涵盖了推动市场总规模预测的因素。该报告致力于提供全球恒温核酸增幅技术（INAAT）市场的最新技术趋势以及产业见解，以协助决策者做出策略决策。此外，我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第三章 全球等恒温核酸增幅技术市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 疾病盛行率上升
      • 更快、更简单的测试
    • 抑制因素
      • 复杂的样品製备
      • 市场竞争
    • 机会
      • 即时检测
      • 新兴市场
    • 任务
      • 监管障碍
      • 技术进步
  • 科技进步/最新发展
  • 法律规范
  • 波特五力分析

第四章 等恒温核酸增幅技术全球市场概况

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
      • 装置
      • 试剂
    • 依技术
      • Helicase-dependent Amplification (HDA)
      • Nicking Enzyme Amplification Reaction (NEAR)
      • Loop-mediated Isothermal Amplification (LAMP)
      • Strand Displacement Amplification (SDA)
      • Nucleic Acid Sequence-based Amplification (NASBA)
      • Transcription Mediated Amplification (TMA)
      • Single Primer Isothermal Amplification (SPIA)
      • 其他的
    • 按用途
      • 验血
      • 感染疾病诊断
      • 癌症
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第五章 北美等恒温核酸增幅技术市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 美国
      • 加拿大

第六章 欧洲恒温核酸增幅技术市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 欧洲其他地区

第七章亚太等恒温核酸增幅技术市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲/纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 其他亚太地区

第八章拉丁美洲恒温核酸增幅技术市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第九章 中东及非洲等恒温核酸增幅技术市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 副产品
    • 依技术
    • 按用途
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 其他中东/非洲

第10章竞争形势

  • 主要企业及产品列表
  • 2022年全球恒温核酸增幅技术市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 主要策略发展（合併、收购、合作伙伴关係等）

第十一章 COVID-19对全球恒温核酸增幅技术市场的影响

第十二章 公司简介

  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.（Gen-Probe）
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD（Becton, Dickinson &Company）
  • OptiGene Limited
  • 其他主要企业

第十三章 关键策略建议

第14章调查方法

简介目录
Product Code: BWC231036

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size More Than Doubles During 2023-2029 to Touch USD 8.44 Billion by 2029

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market is flourishing because of the increasing focus on the treatment and management of rising prevalence of diseases and faster and simplified testing.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market size at USD 4.21 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market size to grow at a significant CAGR of 12.29% reaching a value of USD 8.44 billion by 2029. Major growth drivers for the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market include increasing prevalence of infectious diseases. Diseases such as tuberculosis, hepatitis, and influenza are major contributors to fatalities from infectious diseases, particularly in developing nations. Consequently, there is expected growth in the acceptance of INAAT solutions due to the need for swift, easy-to-use, and disease-specific testing alternatives. Ongoing advancements in existing amplification technologies, coupled with the introduction of innovative methods like Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA), are creating new possibilities for INAAT product applications. These developments are expected to enhance the acceptance of the INAAT during the forecast period. Also, prospective strategic collaborations among manufacturers of INAAT diagnostics and related products are poised to play a pivotal role in augmenting market prospects and fostering industry growth. However, complex sample preparation and market competition are anticipated to restrain the overall market growth during the period in analysis.

Opportunity - Innovative applications of INAAT in emerging markets

Emerging applications for Isothermal Nucleic Acid Amplification Technology (INAAT) products result from the rapid evolution of existing amplification technologies and the introduction of innovative methods like Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA). A noteworthy example is a study, published in the Analyst Journal in June 2022, utilizing the LAMP technology to demonstrate swift Zika virus testing with a smartphone-integrated device, requiring only a single blood drop. These advancements are expected to deepen the penetration of the INAAT during the forecast period.

Impact of COVID-19 on Global Isothermal Nucleic Acid Amplification Technology Market

COVID-19 pandemic had a positive impact on Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market. It led to notable increase in demand for swift and precise testing solutions for the identification of the SARS-CoV-2 (Corona) virus. Various major players in the industry have introduced novel COVID-19 testing products based on INAAT, obtaining emergency use approvals from the US FDA for these products. For instance, commercially available products in this sector encompass Grifols Diagnostic Solutions's Procleix SARS-CoV-2 assay and Lucira Health's Lucira CHECK-IT COVID-19 test kit. Strategic endeavors, prompted by the challenges of the COVID-19 pandemic, are expected to significantly propel market growth during the forecast period.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - By Application

Based on application, the Global Isothermal Nucleic Acid Amplification Technology Market is divided into Blood Screening, Infectious Disease Diagnostics, and Cancer segments. The infectious disease diagnostics segment holds the highest share in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by application. The increasing incidences of infectious diseases, including hepatitis, HIV, herpes, and influenza, along with the efficient diagnosis and treatment facilitated by nucleic acid amplification kits, is expected to propel market expansion. The growing use of point-of-care (PoC) diagnostic tests aids in the early management, treatment, and monitoring of infectious diseases, contributing to market growth. Additionally, heightened awareness and attention towards antimicrobial and epidemic outbreaks are expected to positively influence market growth during the forecast period.

Global Isothermal Nucleic Acid Amplification Technology Market - By Region

The in-depth research report on the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds the highest share in the Global Isothermal Nucleic Acid Amplification Technology Market. The region's dominance is attributed to the high prevalence of chronic diseases, technological advancements in INAAT, and a shift towards INAAT over conventional techniques. In 2020, the Centers for Disease Control and Prevention reported around 157 million Americans with chronic diseases. The GLOBOCAN 2020 data revealed 2,281,658 new cancer cases and 612,390 fatalities in the United States. Also, the substantial per capita healthcare expenditure in North America, expected to reach USD 308 billion, further propels market growth. This region is expected to experience continued market expansion.

Competitive Landscape

Major players operating in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market include Alere, Inc., bioMerieux SA, Eiken Chemical Co. Ltd, Hologic Inc. (Gen-Probe), Meridian Bioscience, Inc., Ustar Biotechnologies Ltd., QIAGEN, Quidel Corporation, Thermo Fisher Scientific, Inc., BD (Becton, Dickinson & Company), and OptiGene Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Isothermal Nucleic Acid Amplification Technology Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising prevalence of diseases
      • 3.2.1.2. Faster and simplified testing
    • 3.2.2. Restraints
      • 3.2.2.1. Complex sample preparation
      • 3.2.2.2. Market competition
    • 3.2.3. Opportunities
      • 3.2.3.1. Point-of-Care testing
      • 3.2.3.2. Emerging markets
    • 3.2.4. Challenges
      • 3.2.4.1. Regulatory hurdles
      • 3.2.4.2. Technological advancements
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Isothermal Nucleic Acid Amplification Technology Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Instruments
      • 4.2.1.2. Reagents
    • 4.2.2. By Technology
      • 4.2.2.1. Helicase-dependent Amplification (HDA)
      • 4.2.2.2. Nicking Enzyme Amplification Reaction (NEAR)
      • 4.2.2.3. Loop-mediated Isothermal Amplification (LAMP)
      • 4.2.2.4. Strand Displacement Amplification (SDA)
      • 4.2.2.5. Nucleic Acid Sequence-based Amplification (NASBA)
      • 4.2.2.6. Transcription Mediated Amplification (TMA)
      • 4.2.2.7. Single Primer Isothermal Amplification (SPIA)
      • 4.2.2.8. Others
    • 4.2.3. By Application
      • 4.2.3.1. Blood Screening
      • 4.2.3.2. Infectious Disease Diagnostics
      • 4.2.3.3. Cancer
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Isothermal Nucleic Acid Amplification Technology Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Technology
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Product
      • 5.2.4.1.2. By Technology
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Product
      • 5.2.4.2.2. By Technology
      • 5.2.4.2.3. By Application

6. Europe Isothermal Nucleic Acid Amplification Technology Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Product
      • 6.2.4.1.2. By Technology
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Product
      • 6.2.4.2.2. By Technology
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Product
      • 6.2.4.3.2. By Technology
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Product
      • 6.2.4.4.2. By Technology
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Product
      • 6.2.4.5.2. By Technology
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Product
      • 6.2.4.6.2. By Technology
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Product
      • 6.2.4.7.2. By Technology
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Product
      • 6.2.4.8.2. By Technology
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Product
      • 6.2.4.9.2. By Technology
      • 6.2.4.9.3. By Application

7. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Product
      • 7.2.4.1.2. By Technology
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Product
      • 7.2.4.2.2. By Technology
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Product
      • 7.2.4.3.2. By Technology
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Product
      • 7.2.4.4.2. By Technology
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Product
      • 7.2.4.5.2. By Technology
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Product
      • 7.2.4.6.2. By Technology
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Product
      • 7.2.4.7.2. By Technology
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Product
      • 7.2.4.8.2. By Technology
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Product
      • 7.2.4.9.2. By Technology
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Product
      • 7.2.4.10.2. By Technology
      • 7.2.4.10.3. By Application

8. Latin America Isothermal Nucleic Acid Amplification Technology Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Product
      • 8.2.4.1.2. By Technology
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Product
      • 8.2.4.2.2. By Technology
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Product
      • 8.2.4.3.2. By Technology
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Product
      • 8.2.4.4.2. By Technology
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Product
      • 8.2.4.5.2. By Technology
      • 8.2.4.5.3. By Application

9. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Product
      • 9.2.4.1.2. By Technology
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Product
      • 9.2.4.2.2. By Technology
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Product
      • 9.2.4.3.2. By Technology
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Product
      • 9.2.4.4.2. By Technology
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Product
      • 9.2.4.5.2. By Technology
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Product
      • 9.2.4.6.2. By Technology
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Product
      • 9.2.4.7.2. By Technology
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Product
      • 9.2.4.8.2. By Technology
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Isothermal Nucleic Acid Amplification Technology Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Isothermal Nucleic Acid Amplification Technology Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Alere, Inc.
  • 12.2. bioMerieux SA
  • 12.3. Eiken Chemical Co. Ltd
  • 12.4. Hologic Inc. (Gen-Probe)
  • 12.5. Meridian Bioscience, Inc.
  • 12.6. Ustar Biotechnologies Ltd.
  • 12.7. QIAGEN
  • 12.8. Quidel Corporation
  • 12.9. Thermo Fisher Scientific, Inc.
  • 12.10. BD (Becton, Dickinson & Company)
  • 12.11. OptiGene Limited
  • 12.12. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations